Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
UC-MSCs by Wuhan Hamilton Bio-technology for Osteoarthritis: Likelihood of Approval
UC-MSCs is under clinical development by Wuhan Hamilton Bio-technology and currently in Phase I for Osteoarthritis. According to GlobalData, Phase...